EGFR and cancer: They confirmed that the specific inhibition of the EGFR mutated allele, represents a safe and effective progress for cancer therapy, also because ASP-RNAi treatment can suppress cancer cell proliferation and growth, regardless of sensitivity to EGFR-TKIs [247].